phospholipase/atrophy

RELATED APPLICATIONS This application is the U.S. National Phase filing under 35 U.S.C. .sctn.371 of PCT/EP2007/058418, filed Aug. 14, 2007, entitled "Method of Preparing a Cake Using Phospholipase", which designated the United States and was published in English on Mar. 6, 2008, which claims

The invention relates to new DNA sequences which code for polypeptides having phospholipase activity essentially without lipase activity. The invention further relates to new polypeptides having phospholipase activity essentially without lipase activity. These polypeptides are acid phospholipases

The invention relates to new DNA sequences which code for polypeptides having phospholipase activity essentially without lipase activity. The invention further relates to new polypeptides having phospholipase activity essentially without lipase activity. These polypeptides are acid phospholipases

TECHNICAL FIELD The invention relates to methods for inhibiting cell death in mammalian cells, particularly in neuronal cells, by administering a suitable inhibitor of phospholipase A.sub.2 activity, typically an inhibitor of cPLA.sub.2 (cytosolic phospholipase A.sub.2); the invention also provides

TECHNICAL FIELD The invention relates to novel peptide molecules and more specifically to a phospholipase A-inhibitory peptide, its synthetic homologs and derivatives thereof. BACKGROUND Group IIA Secretory phospholipase (sPLA.sub.2-IIA) is known to be proinflammatory in vivo (Cirino, G., et al.

BACKGROUND OF THE INVENTION Various chemical and biological agents are currently being used on commercially grown fruit to control the timing of fruit ripening. Such agents can be used for a variety of purposes. One purpose is to synchronize the ripening of fruit to assist in efficient harvesting of